Cargando…
Targeting Myeloid-Derived Suppressor Cells to Enhance a Trans-Sialidase-Based Vaccine Against Trypanosoma cruzi
Trypanosoma cruzi (T. cruzi) is a hemoflagellate protozoan parasite that causes Chagas disease, a neglected tropical disease that affects more than 6 million people around the world, mostly in Latin America. Despite intensive research, there is no vaccine available; therefore, new approaches are nee...
Autores principales: | Gamba, Juan Cruz, Roldán, Carolina, Prochetto, Estefanía, Lupi, Giuliana, Bontempi, Iván, Poncini, Carolina Verónica, Vermeulen, Mónica, Pérez, Ana Rosa, Marcipar, Iván, Cabrera, Gabriel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8290872/ https://www.ncbi.nlm.nih.gov/pubmed/34295832 http://dx.doi.org/10.3389/fcimb.2021.671104 |
Ejemplares similares
-
Trans-sialidase-based vaccine candidate protects against Trypanosoma cruzi infection, not only inducing an effector immune response but also affecting cells with regulatory/suppressor phenotype
por: Prochetto, Estefanía, et al.
Publicado: (2017) -
Trypanosoma cruzi trans-Sialidase as a Potential Vaccine Target Against Chagas Disease
por: da Costa, Kelli Monteiro, et al.
Publicado: (2021) -
Modulatory Effect of Trypanosoma cruzi Infective Stages in Different Dendritic Cell Populations in vitro
por: Gutierrez, Brenda Celeste, et al.
Publicado: (2020) -
Early Immune Response Elicited by Different Trypanosoma cruzi Infective Stages
por: Gutierrez, Brenda Celeste, et al.
Publicado: (2021) -
Extracellular vesicles from Trypanosoma cruzi-dendritic cell interaction show modulatory properties and confer resistance to lethal infection as a cell-free based therapy strategy
por: Gutierrez, Brenda Celeste, et al.
Publicado: (2022)